A detailed history of Impax Asset Management Group PLC transactions in Baxter International Inc stock. As of the latest transaction made, Impax Asset Management Group PLC holds 708,525 shares of BAX stock, worth $23.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
708,525
Previous 708,525 -0.0%
Holding current value
$23.5 Million
Previous $26.9 Million -0.0%
% of portfolio
0.12%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$32.85 - $40.26 $2.03 Million - $2.49 Million
-61,752 Reduced 8.02%
708,525 $26.9 Million
Q2 2024

Nov 08, 2024

BUY
$32.87 - $43.55 $2.03 Million - $2.69 Million
61,752 Added 8.72%
770,277 $25.8 Million
Q2 2024

Aug 05, 2024

SELL
$32.87 - $43.55 $6.48 Million - $8.58 Million
-197,031 Reduced 20.37%
770,277 $25.8 Million
Q1 2024

Apr 30, 2024

SELL
$37.88 - $43.77 $7.7 Million - $8.9 Million
-203,347 Reduced 17.37%
967,308 $41.3 Million
Q4 2023

Jan 26, 2024

BUY
$31.71 - $38.95 $11.8 Million - $14.5 Million
373,409 Added 46.84%
1,170,655 $45.3 Million
Q3 2023

Nov 07, 2023

SELL
$37.32 - $49.29 $1.53 Million - $2.02 Million
-40,954 Reduced 4.89%
797,246 $30.1 Million
Q2 2023

Aug 07, 2023

BUY
$39.98 - $47.68 $2.76 Million - $3.29 Million
69,105 Added 8.99%
838,200 $38.2 Million
Q1 2023

May 10, 2023

BUY
$37.58 - $52.57 $7.37 Million - $10.3 Million
196,188 Added 34.24%
769,095 $31.2 Million
Q4 2022

Feb 09, 2023

BUY
$49.7 - $57.71 $28.5 Million - $33.1 Million
572,907 New
572,907 $29.2 Million
Q1 2022

May 16, 2022

SELL
$76.85 - $89.45 $1,229 - $1,431
-16 Reduced 0.52%
3,061 $237,000
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $6,338 - $7,411
-85 Reduced 2.69%
3,077 $264,000
Q1 2021

May 14, 2021

BUY
$76.38 - $86.03 $241,513 - $272,026
3,162 New
3,162 $267,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Impax Asset Management Group PLC Portfolio

Follow Impax Asset Management Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.